| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.019 | 0.9 |